medical cannabis
medical cannabis · page 2
- Cultivation
Irradiated Medical Cannabis and the Science Behind the Debate
James Duckenfield, CEO of Glass Pharms®, examines what irradiation changes in medical cannabis flower, what it leaves behind, and why understanding microbial quality requires a closer look at the science.
- Cultivation
Dutch Cannabis Patients Facing 10-Month Supply Gap, Many With ‘No Therapeutic Alternative’
Thousands of Dutch patients are facing a 10-month supply gap for medically essential Bedrocan products, including varieties clinicians consider irreplaceable for children with treatment-resistant epilepsy.
- Medical Cannabis
Germany to Soften Cannabis Insurance Reforms as Exilby Lobbying Row Escalates
Germany’s coalition government has retreated further on its controversial medical cannabis reimbursement reforms as it faces mounting questions over how and why the law came to be.
- Press releases
Curaleaf Laboratories and Vericura Announce Distribution Agreement to Expand UK Manufacturing and Distribution of Medical Cannabis Products
Curaleaf Laboratories and Vericura today announced an agreement to strengthen the manufacturing and distribution of medical cannabis products across the United Kingdom.
- Medical Cannabis
Medical Cannabis Pioneer Bedrocan Fights to Avoid Bankruptcy in Home Market
Bedrocan, the Dutch medical cannabis stalwart thousands of patients rely on for their prescriptions, is now fighting to avoid collapse.
- Medical Cannabis
Overdue ACMD Report Gets New Deadline as Industry Weighs In
By Ben Stevens, with additional reporting by Nicole Farah, Managing Director of Americana Communications.
- Cultivation
France’s PGP Farmer Selects 5 Cannabis Strains for Future French Production as Market Nears Rollout
PGP Farmer, the French biotech building the country’s first EU-GMP medical cannabis production site, has narrowed a 30-variety Dutch phenotyping trial to five elite cultivars, laying the agronomic groundwork for its 9-hectare Dordogne facility as France closes on the reforms needed for full medical cannabis rollout.
- Data & Analysis
Cannabis Legalisation in the UK: Where the Law Actually Stands and What Could Change
In the UK, cannabis remains a Class B drug under the Misuse of Drugs Act 1971, meaning the possession, supply and cultivation for recreational purposes are all criminal offences carrying significant potential sentences.
- Cultivation
Are We Underestimating the Pharmaceutical Potential of the Cannabis Plant?
James Duckenfield, CEO of Glass Pharms®, explains why we may be underestimating the pharmaceutical potential of cannabis, and how research, formulation and more controlled delivery could help realise it.
- Data & Analysis
Is Cannabis Legal in Germany in 2026? The Law, the Market and What It Means for Operators
Is cannabis legal in Germany? No, not in the way it is in the majority of US states or Canada.
- International Regulation
Australia’s Medical Cannabis Reforms to Target ‘Closed Loop’ Prescribing
Australia’s ongoing efforts to restrict its medical cannabis market, now the largest outside North America, are now taking aim at the special access scheme (SAS) framework on which the country’s hundreds of thousands of annual prescriptions are based.
- Medical Cannabis
Majority of UK Medical Cannabis Flower Now at 25% THC or Above, New Data Shows
Earlier this month, we published new data from two separate Freedom of Information (FOI) requests providing the most complete and up-to-date picture yet of the UK’s medical cannabis market.
